CLINICAL_TRIALS
ClinicalTrials.gov record update
Efficacy of COVID-19 Booster-Dose Vaccine for Re-infection Precaution and Dynamics of Specific Serum Antibodies in the Management of Lung Cancer Patients With Systemic Anti-cancer Treatment
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT06168032
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:39:24.929842+00:00
- Published At
- 2023-12-13T00:00:00+00:00
- Record Updated At
- 2023-12-13
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["COVID-19 Recurrent", "Lung Cancer", "Vaccination", "Antibody", "Chemotherapy", "Immune Checkpoint Inhibitor"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-12-13"- protocolSection.identificationModule.nctId
"NCT06168032"- protocolSection.identificationModule.officialTitle
"Efficacy of COVID-19 Booster-Dose Vaccine for Re-infection Precaution and Dynamics of Specific Serum Antibodies in the Management of Lung Cancer Patients With Systemic Anti-cancer Treatment"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["NA"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.